Page last updated: 2024-08-24

thomsen-friedenreich antigen and Angiogenesis, Pathologic

thomsen-friedenreich antigen has been researched along with Angiogenesis, Pathologic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, H; Bandyopadhyaya, G; Davila, E; Guha, P; Kaczanowska, S; Kalvakolanu, DV; Kaptan, E; Martin, SS; Thompson, K; Vasta, GR1
Yu, LG1

Reviews

1 review(s) available for thomsen-friedenreich antigen and Angiogenesis, Pathologic

ArticleYear
The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.
    Glycoconjugate journal, 2007, Volume: 24, Issue:8

    Topics: Antigens, Tumor-Associated, Carbohydrate; Cell Adhesion; Cell Proliferation; Disease Progression; Endothelium; Humans; Mucin-1; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic

2007

Other Studies

1 other study(ies) available for thomsen-friedenreich antigen and Angiogenesis, Pathologic

ArticleYear
Cod glycopeptide with picomolar affinity to galectin-3 suppresses T-cell apoptosis and prostate cancer metastasis.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, Mar-26, Volume: 110, Issue:13

    Topics: Adenocarcinoma; Animals; Antifreeze Proteins; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Agents; Apoptosis; Fish Proteins; Gadus morhua; Galectin 3; Human Umbilical Vein Endothelial Cells; Humans; Jurkat Cells; Male; Mice; Neoplasm Metastasis; Neoplasm Proteins; Neovascularization, Pathologic; Prostatic Neoplasms; T-Lymphocytes

2013